Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Abstract
Up-to-date estimates of stroke burden and attributable risks and their trends at global, regional, and national levels are essential for evidence-based health care, prevention, and resource allocation planning. We aimed to provide such estimates for the period 1990-2021.
We estimated incidence, prevalence, death, and disability-adjusted life-year (DALY) counts and age-standardised rates per 100 000 people per year for overall stroke, ischaemic stroke, intracerebral haemorrhage, and subarachnoid haemorrhage, for 204 countries and territories from 1990 to 2021. We also calculated burden of stroke attributable to 23 risk factors and six risk clusters (air pollution, tobacco smoking, behavioural, dietary, environmental, and metabolic risks) at the global and regional levels (21 GBD regions and Socio-demographic Index [SDI] quintiles), using the standard GBD methodology. 95% uncertainty intervals (UIs) for each individual future estimate were derived from the 2·5th and 97·5th percentiles of distributions generated from propagating 500 draws through the multistage computational pipeline.
Citation impact
- FWCI
- 393.69
- Percentile
- 100%
- References
- 53
Authors
1403Topics & keywords
- Burden of disease
- Stroke (engine)
- Disease
- Medicine
- Environmental health
- Internal medicine
- Engineering
Funding
- UDU.S. Department of Defense
- ADAmerican Diabetes Association
- BABill and Melinda Gates Foundation
- AAAlzheimer's Association
- AHAmerican Heart Association
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- BBayer
- SSanofi
- AVAlexander von Humboldt-Stiftung
- BBiogen
- TPTeva Pharmaceutical Industries
- APAlexion Pharmaceuticals
- KDKorean Diabetes Association
- DDanone
- JHJohns Hopkins University
- RPRegeneron Pharmaceuticals
- ISInternational Society of Travel Medicine
- UPUltragenyx Pharmaceutical
- ACAmarin Corporation
- IHInternational Hepato-Pancreato-Biliary Association
- ATAmicus Therapeutics
- GBGlobal Brain Health Institute
- FMFresenius Medical Care North America
- APAgios Pharmaceuticals
- NCNational Cerebral and Cardiovascular Center
- APAmryt Pharma
- SMSociedad Madrileña de Nefrología
- CHCardinal Health
- MModerna
- GOGovernment of Canada
- ECEuropean CommissionAward: RRF-2.3.1-21-2022-00006
- CUCardiff University
- AAAustralian Academy of Science
- NRNational Research Foundation
- DFDeutsche ForschungsgemeinschaftAward: 2020-2023
- MOMinistry of Education, Culture, Sports, Science and TechnologyAwards: 2020-2023, 21H03203
- KSKing Saud UniversityAward: RSP-2024 R47
- AAOSpine
- FCFondazione Cariplo
- GDGeneralitat de Catalunya
- MDMinistero della Salute
- CNConselho Nacional de Desenvolvimento Científico e TecnológicoAwards: 316607/2021-5, 304224/2022-7
- NRNational Research Foundation of KoreaAward: 2020H1D3A1A04081265
- EEisai
- NNNovo Nordisk
- IAInternational Atomic Energy Agency
- APAstellas Pharma
- UOUniversity of Jordan
- IAIstituto Auxologico Italiano
- SServier
- AAAfrican Academy of Sciences
- SOSwedish Orphan Biovitrum
- CRCasen Recordati
- HLH. Lundbeck A/S
- MOMinistry of Science and ICT, South KoreaAward: 2020H1D3A1A04081265
- IItalfarmaco
- NNeuraxpharm
- IPIdorsia Pharmaceuticals
- LDLilly Deutschland
- IPIntas Pharmaceuticals
- NSNational Science and Technology Council
- ETEsperion Therapeutics
- ESEuropean Stroke Organisation
- NINational Institutes of HealthAwards: 2020-2023, R01AG072547, U19AG074865
- AAllergan
- NPNovartis Pharma
- NNNovo Nordisk Pharma
- CICanadian Institutes of Health Research
- MRMedical Research CouncilAward: MR/M015084/1
- NHNational Health and Medical Research CouncilAwards: APP2009306, 2009295
- JSJapan Society for the Promotion of ScienceAwards: 201034, 21H03203
- JSJapan Science and Technology AgencyAward: JPMJPR22R8
- NRNational Research, Development and Innovation OfficeAward: RRF-2.3.1-21-2022-00006
- DNDSM Nutritional Products
- PRPrecursory Research for Embryonic Science and TechnologyAward: JPMJPR22R8
- DSDaiichi Sankyo Europe
- CCilag